These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 23286294)
21. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs. Fiorucci S; Distrutti E Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233 [TBL] [Abstract][Full Text] [Related]
22. The cardiovascular pharmacology of COX-2 inhibition. Fries S; Grosser T Hematology Am Soc Hematol Educ Program; 2005; ():445-51. PubMed ID: 16304418 [TBL] [Abstract][Full Text] [Related]
23. What price pain relief? Hochman JS; Shah NR Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335 [No Abstract] [Full Text] [Related]
30. [NSAIDs and cardiovascular and renal complications]. Valat JP Presse Med; 2006 Sep; 35(9 Spec No 1):1S3-4. PubMed ID: 17080562 [No Abstract] [Full Text] [Related]
31. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Fosslien E Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252 [TBL] [Abstract][Full Text] [Related]
32. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. ; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048 [No Abstract] [Full Text] [Related]
33. Risk-benefit perspectives in COX-2 blockade. Dabu-Bondoc S; Franco S Curr Drug Saf; 2008 Jan; 3(1):14-23. PubMed ID: 18690976 [TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 inhibitors: a painful lesson. Sanghi S; MacLaughlin EJ; Jewell CW; Chaffer S; Naus PJ; Watson LE; Dostal DE Cardiovasc Hematol Disord Drug Targets; 2006 Jun; 6(2):85-100. PubMed ID: 16787194 [TBL] [Abstract][Full Text] [Related]
35. Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives. Bruno A; Tacconelli S; Patrignani P Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):56-63. PubMed ID: 23953622 [TBL] [Abstract][Full Text] [Related]
36. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Strand V Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036 [TBL] [Abstract][Full Text] [Related]
37. Selective cyclooxygenase inhibitors: current status. Nandakishore R; Yalavarthi PR; Kiran YR; Rajapranathi M Curr Drug Discov Technol; 2014 Jun; 11(2):127-32. PubMed ID: 24467591 [TBL] [Abstract][Full Text] [Related]
38. Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? Mukherjee D Congest Heart Fail; 2008; 14(2):75-82. PubMed ID: 18401215 [TBL] [Abstract][Full Text] [Related]